NEUROCRINE BIOSCIENCES INC (NBIX) Gross profit 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) annual gross profit history from SEC filings — each fiscal year as reported.
$2.8BFY2025 · since FY2016: $15.0M → $2.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.8B | +21.0% |
| FY2024 | $2.3B | +25.7% |
| FY2023 | $1.8B | +26.1% |
| FY2022 | $1.5B | +30.9% |
| FY2021 | $1.1B | +8.1% |
| FY2020 | $1.0B | — |
| FY2018 | $446.3M | +178.3% |
| FY2017 | $160.4M | +969.1% |
| FY2016 | $15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NBIX financial trends
NBIX RevenueNBIX Net incomeNBIX Net marginNBIX Gross marginNBIX Operating incomeNBIX Operating marginNBIX Operating cash flowNBIX Free cash flowNBIX Capital expendituresNBIX Return on equityNBIX Stock buybacksNBIX Dividends paidNBIX Total assetsNBIX Total liabilitiesNBIX Shareholders’ equityNBIX overview →